Lower Level of Bacteroides in the Gut Microbiota Is Associated with Inflammatory Bowel Disease: A Meta-Analysis

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Zhou, Yingting ^a   Zhi, Fachao ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEROIDES; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL (TOPIC); CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ASSOCIATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; META ANALYSIS; OBSERVATIONAL STUDY; REMISSION; REVIEW; ULCERATIVE COLITIS; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY;

BACTEROIDES; COLITIS, ULCERATIVE; CROHN DISEASE; GASTROINTESTINAL MICROBIOME; HUMANS;

EID: 85004147192     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/5828959     Document Type: Review

References (28)

1. M. T. Osterman, R. Kundu, G. R. Lichtenstein, and J. D. Lewis, "Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis, " Gastroenterology, vol. 130, no. 4, pp. 1047-1053, 2006.
2. R. Srinivasan and A. K. Akobeng, "Thalidomide and thalidomide analogues for induction of remission in Crohn's disease, " Cochrane Database of Systematic Reviews, no. 2, Article ID CD007350, 2009.
3. C. J. Damman, S. I. Miller, C. M. Surawicz, and T. L. Zisman, "The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation, " The American Journal of Gastroenterology, vol. 107, no. 10, pp. 1452-1459, 2012.
4. P. B. Eckburg, E. M. Bik, C. N. Bernstein et al., "Microbiology: diversity of the human intestinal microbial flora, " Science, vol. 308, no. 5728, pp. 1635-1638, 2005.
5. R. E. Ley, C. A. Lozupone, M. Hamady, R. Knight, and J. I. Gordon, "Worlds within worlds: evolution of the vertebrate gut microbiota, " Nature Reviews Microbiology, vol. 6, no. 10, pp. 776-788, 2008.
6. S. Houston, G. W. Blakely, A. McDowell, L. Martin, and S. Patrick, "Binding and degradation of fibrinogen by Bacteroides fragilis and characterization of a 54 kDa fibrinogen-binding protein, " Microbiology, vol. 156, no. 8, pp. 2516-2526, 2010.
7. J. L. Round, S. M. Lee, J. Li et al., "The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota, " Science, vol. 332, no. 6032, pp. 974-977, 2011.
8. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, "Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, " International Journal of Surgery, vol. 8, no. 5, pp. 336-341, 2010.
9. D. F. Stroup, J. A. Berlin, S. C. Morton et al., "Meta-analysis of observational studies in epidemiology: a proposal for reporting, " Journal of the American Medical Association, vol. 283, no. 15, pp. 2008-2012, 2000.
10. F. Brito, C. Zaltman, A. T. P. Carvalho et al., "Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis, " European Journal of Gastroenterology and Hepatology, vol. 25, no. 2, pp. 239-245, 2013.
11. M. P. Conte, S. Schippa, I. Zamboni et al., "Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease, " Gut, vol. 55, no. 12, pp. 1760-1767, 2006.
12. M. Mylonaki, N. B. Rayment, D. S. Rampton, B. N. Hudspith, and J. Brostoff, "Molecular characterization of rectal mucosaassociated bacterial flora in inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 11, no. 5, pp. 481-487, 2005.
13. F. C. Nwosu, L.-T. Thorkildsen, E. Avershina et al., "Agedependent fecal bacterial correlation to inflammatory bowel disease for newly diagnosed untreated children, " Gastroenterology Research and Practice, vol. 2013, Article ID 302398, 7 pages, 2013.
14. K.-L. Kolho, K. Korpela, T. Jaakkola et al., "Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation, " American Journal of Gastroenterology, vol. 110, no. 6, pp. 921-930, 2015.
15. A. Andoh, H. Kuzuoka, T. Tsujikawa et al., "Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease, " Journal of Gastroenterology, vol. 47, no. 12, pp. 1298-1307, 2012.
16. S. Ashorn, T. Honkanen, K.-L. Kolho et al., "Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 15, no. 2, pp. 199-205, 2009.
17. C. Basset, J. Holton, A. Bazeos, D. Vaira, and S. Bloom, "Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?" Digestive Diseases and Sciences, vol. 49, no. 9, pp. 1425-1432, 2004.
18. B. Kleessen, A. J. Kroesen, H. J. Buhr, and M. Blaut, "Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls, " Scandinavian Journal of Gastroenterology, vol. 37, no. 9, pp. 1034-1041, 2002.
19. H. Sokol, P. Seksik, L. Rigottier-Gois et al., "Specificities of the fecal microbiota in inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 12, no. 2, pp. 106-111, 2006.
20. A. Swidsinski, A. Ladhoff, A. Pernthaler et al., "Mucosal flora in inflammatory bowel disease, " Gastroenterology, vol. 122, no. 1, pp. 44-54, 2002.
21. A. Swidsinski, J. Weber, V. Loening-Baucke, L. P. Hale, and H. Lochs, "Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease, " Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3380-3389, 2005.
22. H. Takaishi, T. Matsuki, A. Nakazawa et al., "Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease, " International Journal of Medical Microbiology, vol. 298, no. 5-6, pp. 463-472, 2008.
23. A. Andoh, H. Imaeda, T. Aomatsu et al., "Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis, " Journal of Gastroenterology, vol. 46, no. 4, pp. 479-486, 2011.
24. R. K. Linskens, X. W. Huijsdens, P. H. M. Savelkoul, C. M. J. E. Vandenbrouckc-Grauls, and S. G. M. Meuwissen, "The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics, " Scandinavian Journal of Gastroenterology. Supplement, vol. 36, no. 234, pp. 29-40, 2001.
25. P. Desreumaux and J.-F. Colombel, "Intestinal flora and Crohn's disease, " Annales Pharmaceutiques Francaises, vol. 61, no. 4, pp. 276-281, 2003.
26. A. Schwiertz, M. Jacobi, J.-S. Frick, M. Richter, K. Rusch, and H. Köhler, "Microbiota in pediatric inflammatory bowel disease, " The Journal of Pediatrics, vol. 157, no. 2, pp. 240-244. e1, 2010.
27. S. Matsumoto, N. Watanabe, A. Imaoka, and Y. Okabe, "Preventive effects of Bifidobacterium-and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice, " Digestion, vol. 64, no. 2, pp. 92-99, 2001.
28. A. Swidsinski, V. Loening-Baucke, and A. Herber, "Mucosal flora in Crohn's disease and ulcerative colitis-an overview, " Journal of Physiology and Pharmacology, vol. 60, supplement 6, pp. 61-71, 2009.